Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Earnings

Wolfspeed Shares Plunge on Disappointing Revenue Outlook

Dieter Jaworski by Dieter Jaworski
October 30, 2025
in Earnings, Semiconductors, TecDAX
0
Wolfspeed Stock
0
SHARES
12
VIEWS
Share on FacebookShare on Twitter

Semiconductor manufacturer Wolfspeed jolted investors with a sobering financial forecast, triggering a sharp decline in its share price. Despite reporting better-than-anticipated quarterly results following its recent bankruptcy exit, the company’s guidance for the upcoming quarter sent its stock tumbling 10.8% in after-hours trading.

Bankruptcy Exit Overshadowed by Weak Guidance

The primary catalyst for the sell-off was Wolfspeed’s second-quarter revenue projection, which fell substantially short of market expectations. The company anticipates revenue between $150 million and $190 million, a figure that lands well below the analyst consensus estimate of approximately $202.7 million. This significant forecast miss has raised serious concerns about the firm’s near-term growth trajectory.

Having formally emerged from Chapter 11 bankruptcy protection on September 29, Wolfspeed presented its first post-restructuring earnings. For the first quarter of fiscal year 2026, the company posted consolidated revenue of $197 million.

While the adjusted loss per share of $0.55 was narrower than feared, the GAAP loss per share reached a substantial $4.12. This wider loss was primarily driven by $504 million in reorganization expenses tied to the bankruptcy process.

Should investors sell immediately? Or is it worth buying Wolfspeed?

Operational Headwinds and Financial Health

A particularly alarming development was the severe contraction in the company’s adjusted gross margin, which plummeted to negative 26% compared to a positive 3% during the same period last year. Management attributed this deterioration to $47 million in underutilization costs at its Mohawk Valley and Siler City manufacturing facilities.

Key Financial Metrics:
* Q1 Revenue: $197 million
* Q1 Adjusted Loss Per Share: $0.55
* Q1 GAAP Loss Per Share: $4.12
* Q2 Revenue Guidance: $150-$190 million
* Liquidity: $926 million in cash and short-term investments

The company further cautioned that persistent market softness is expected to continue throughout fiscal 2026, indicating that the path back to sustained profitability remains a formidable challenge for the chipmaker.

Ad

Wolfspeed Stock: Buy or Sell?! New Wolfspeed Analysis from February 7 delivers the answer:

The latest Wolfspeed figures speak for themselves: Urgent action needed for Wolfspeed investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Wolfspeed: Buy or sell? Read more here...

Tags: Wolfspeed
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

ServiceNow Stock
AI & Quantum Computing

ServiceNow Shares Face Market Skepticism Despite Record Performance

February 7, 2026
Orthofix Medical Stock
Earnings

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

February 7, 2026
Myers Industries Stock
Analysis

Myers Industries Set to Report Full-Year and Q4 2025 Results

February 7, 2026
Next Post
Vulcan Energy Stock

Vulcan Energy Secures Major Glencore Agreement, Finalizing Phase One Funding

Quantum eMotion Stock

Quantum Security Firm Gains Momentum with Major Commercial Breakthrough

Nel ASA Stock

Hydrogen Specialist Nel ASA Reports Conflicting Quarterly Signals

Recommended

Technology Artificial intelligence Market Capitalization

Analyst Reaffirms Positive Outlook on Airgain with Price Target Increase Chief Revenue Officer Resigns

2 years ago
COST stock news

Apples Official Obsolescence of the 2012 MacBook Pro 13inch Model

2 years ago
Hain Celestial Stock

Hain Celestial Faces Critical Test with Upcoming Earnings Release

6 months ago
Piper Jaffray Stock

Mixed Signals Emerge from Piper Sandler’s Strong Quarterly Performance

6 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

A New Chapter for First Busey as CrossFirst Merger Finalizes

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Riley Exploration Permian Bolsters Board with Industry Veteran Amid Shareholder Activity

Great Lakes Dredge & Dock: A Cash Flow Inflection Point Approaches

Trending

Yirendai Stock
AI & Quantum Computing

Yirendai Charts a New Course with Tech-Driven Strategy

by Kennethcix
February 7, 2026
0

The Chinese fintech firm Yirendai is actively pursuing a strategic pivot, embedding advanced technologies like blockchain and...

ServiceNow Stock

ServiceNow Shares Face Market Skepticism Despite Record Performance

February 7, 2026
Orthofix Medical Stock

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

February 7, 2026
CrossFirst Bankshares Stock

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026
Golden Entertainment Stock

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Yirendai Charts a New Course with Tech-Driven Strategy
  • ServiceNow Shares Face Market Skepticism Despite Record Performance
  • Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com